Search hospitals > Michigan > Saint Joseph
Lakeland Medical Center Saint Joseph
Claim this profileSaint Joseph, Michigan 49085
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Tumors
204 reported clinical trials
1 medical researcher
Summary
Lakeland Medical Center Saint Joseph is a medical facility located in Saint Joseph, Michigan. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Tumors and other specialties. Lakeland Medical Center Saint Joseph is involved with conducting 204 clinical trials across 393 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Clinical Trials running at Lakeland Medical Center Saint Joseph
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Pancreatic Cancer
Melanoma
Multiple Myeloma
Cutaneous Melanoma
Anal Cancer
Ovarian Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Lakeland Medical Center Saint Joseph?
Lakeland Medical Center Saint Joseph is a medical facility located in Saint Joseph, Michigan. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Tumors and other specialties. Lakeland Medical Center Saint Joseph is involved with conducting 204 clinical trials across 393 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.